DE69823369D1 - Antistress wirkstoffe und funktionelle lebensmittel - Google Patents

Antistress wirkstoffe und funktionelle lebensmittel

Info

Publication number
DE69823369D1
DE69823369D1 DE69823369T DE69823369T DE69823369D1 DE 69823369 D1 DE69823369 D1 DE 69823369D1 DE 69823369 T DE69823369 T DE 69823369T DE 69823369 T DE69823369 T DE 69823369T DE 69823369 D1 DE69823369 D1 DE 69823369D1
Authority
DE
Germany
Prior art keywords
antistress
pro
active substances
agents
functional foodstuffs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69823369T
Other languages
English (en)
Other versions
DE69823369T2 (de
Inventor
Akihiro Masuyama
Toshiaki Takano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Soft Drinks Co Ltd
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of DE69823369D1 publication Critical patent/DE69823369D1/de
Publication of DE69823369T2 publication Critical patent/DE69823369T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
DE69823369T 1997-09-26 1998-02-05 Antistress wirkstoffe und funktionelle lebensmittel Expired - Lifetime DE69823369T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26242297A JP4727770B2 (ja) 1997-09-26 1997-09-26 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
JP26242297 1997-09-26
PCT/JP1998/000480 WO1999016461A1 (fr) 1997-09-26 1998-02-05 Agents antistress et aliments fonctionnels

Publications (2)

Publication Number Publication Date
DE69823369D1 true DE69823369D1 (de) 2004-05-27
DE69823369T2 DE69823369T2 (de) 2005-05-04

Family

ID=17375571

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823369T Expired - Lifetime DE69823369T2 (de) 1997-09-26 1998-02-05 Antistress wirkstoffe und funktionelle lebensmittel

Country Status (23)

Country Link
US (1) US6410685B1 (de)
EP (1) EP1018341B1 (de)
JP (1) JP4727770B2 (de)
KR (2) KR100383492B1 (de)
CN (1) CN1198641C (de)
AT (1) ATE264687T1 (de)
AU (1) AU728565B2 (de)
BG (1) BG64692B1 (de)
BR (1) BR9813222A (de)
CA (1) CA2303810C (de)
CZ (1) CZ298848B6 (de)
DE (1) DE69823369T2 (de)
DK (1) DK1018341T3 (de)
ES (1) ES2219868T3 (de)
HU (1) HUP0004617A3 (de)
ID (1) ID25635A (de)
IN (1) IN190794B (de)
PL (1) PL192873B1 (de)
PT (1) PT1018341E (de)
SK (1) SK285148B6 (de)
TR (1) TR200000863T2 (de)
TW (1) TWI231213B (de)
WO (1) WO1999016461A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
DE10105041A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
US20050256057A1 (en) 2002-06-04 2005-11-17 Luppo Edens Protein hydrolysate rich in tripeptides
US20050222263A1 (en) * 2002-09-18 2005-10-06 Ajinomoto Co., Inc. Compositions against stress-related diseases and methods for treating stress-related diseases
AU2003264431A1 (en) * 2002-09-18 2004-04-08 Ajinomoto Co., Inc. Composition against stress-related diseases
TWI344371B (en) 2003-03-18 2011-07-01 Suntory Holdings Ltd Angiotensin-converting enzyme inhibitory peptides
ZA200507880B (en) * 2003-05-05 2006-12-27 Unilever Plc Hydrolysed casein product comprising tripeptides IPP and/or VPP
WO2005096847A1 (en) * 2004-03-19 2005-10-20 Campina Nederland Holding B.V. Method of preparing a food ingredient and food product having angiotensin-i-converting enzyme inhibiting properties and products thus obtained
JP2008505653A (ja) * 2004-07-12 2008-02-28 ディーエスエム アイピー アセッツ ビー．ブイ． 血圧降下タンパク質加水分解物
ES2599859T3 (es) * 2005-02-24 2017-02-03 Dsm Ip Assets B.V. Proceso enzimático para producir I-P-P a partir de caseína kappa
WO2007013426A1 (ja) * 2005-07-26 2007-02-01 Calpis Co., Ltd. 発酵乳の製造方法及び発酵乳飲食品
WO2007079977A2 (en) * 2006-01-16 2007-07-19 Dsm Ip Assets B.V. Nutraceutical compositions comprising tripeptides
CN101443031A (zh) * 2006-05-15 2009-05-27 瓦利奥有限公司 治疗用肽的新应用
JP5394628B2 (ja) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 新規なラクトバチルス属微生物および乳酸菌製剤
CN101909645A (zh) * 2007-11-14 2010-12-08 帝斯曼知识产权资产管理有限公司 包含ipp和/或vpp的降血压组合
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2011136932A (ja) * 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
JP2011102331A (ja) * 2011-02-17 2011-05-26 Calpis Co Ltd 尿中ドーパミン低下の予防及び軽減剤
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2014208702A (ja) * 2014-07-31 2014-11-06 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
CN104725485B (zh) * 2014-11-19 2018-01-16 扬州大学 一种重组活性肽及其同步制备方法
JPWO2017057319A1 (ja) * 2015-09-30 2018-07-19 株式会社明治 乳酸菌スターターの調製方法及び発酵乳の製造方法
CN111909978B (zh) * 2020-07-10 2021-06-22 青岛农业大学 一种利用发酵法从玉米蛋白粉中定向制备富含lpp水解物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189064A (en) * 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
ATE124867T1 (de) * 1989-02-16 1995-07-15 Sankyo Co Peptide, die eine reninhemmende aktivität besitzen, deren herstellung und verwendung.
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US5604198A (en) * 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
JPH08275752A (ja) * 1995-04-07 1996-10-22 Riken Vitamin Co Ltd ストレス改善食品
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤

Also Published As

Publication number Publication date
DE69823369T2 (de) 2005-05-04
BG64692B1 (bg) 2005-12-30
SK285148B6 (sk) 2006-07-07
ID25635A (id) 2000-10-19
KR20030005137A (ko) 2003-01-15
KR20010024277A (ko) 2001-03-26
PL339348A1 (en) 2000-12-18
TR200000863T2 (tr) 2000-11-21
PL192873B1 (pl) 2006-12-29
HUP0004617A2 (hu) 2001-05-28
CN1279614A (zh) 2001-01-10
EP1018341A1 (de) 2000-07-12
KR100379819B1 (ko) 2003-04-14
ES2219868T3 (es) 2004-12-01
US6410685B1 (en) 2002-06-25
CZ298848B6 (cs) 2008-02-27
CA2303810C (en) 2007-03-27
PT1018341E (pt) 2004-08-31
TWI231213B (en) 2005-04-21
HUP0004617A3 (en) 2001-11-28
ATE264687T1 (de) 2004-05-15
IN190794B (de) 2003-08-23
CA2303810A1 (en) 1999-04-08
CZ20001083A3 (cs) 2001-01-17
JP4727770B2 (ja) 2011-07-20
EP1018341A4 (de) 2002-08-28
EP1018341B1 (de) 2004-04-21
DK1018341T3 (da) 2004-07-26
CN1198641C (zh) 2005-04-27
SK4362000A3 (en) 2001-03-12
AU5780198A (en) 1999-04-23
BG104381A (en) 2001-02-28
BR9813222A (pt) 2000-08-29
KR100383492B1 (ko) 2003-05-12
JPH11100328A (ja) 1999-04-13
WO1999016461A1 (fr) 1999-04-08
AU728565B2 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
DE69823369D1 (de) Antistress wirkstoffe und funktionelle lebensmittel
CA2223510A1 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
BR0313548A (pt) Produto alimentìcio com base em cereal compreendendo dha e/ou epa
EP0966969A4 (de) Anti-stress wirkstoffe und funktionale nährstoffe mit anti-stress effekten
CA2268439A1 (en) Citrus peel extract as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor
WO2003013549A3 (de) Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
BR9507752A (pt) Cepas de lactobacilos de origem humanan suas composições e seus usos
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
ATE238692T1 (de) Behandlung von obst und gemüse
WO2002007533A3 (en) Nutritional composition
CA2132369A1 (en) Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances
WO1997040072A3 (en) Adam proteins and uses thereof
ATE252389T1 (de) Ein arzneimittel zur behandlung von fettleibigkeit und verbesserung des lipidmetabolismus
CA2128711A1 (en) Trypsin inhibitors
DE60023657D1 (de) Inhibitore der verzweigte-aminosäure-abhängigen aminotransferase und deren verwendung in der behandlung der zuckerkranke retinopathie
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
EP1690869A4 (de) Ein das angiontensin converting enzyme hemmendes peptid
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE19981729D2 (de) Pharmazeutisches und/oder diätetisches Produkt
DE60239293D1 (de) Konservierung von gemüse und kräutern
DE69902879D1 (de) Pflanzliches antivirales mittel
WO2000059531A3 (en) Therapeutic uses of bpi protein products in bpi-deficient humans
PL367613A1 (en) Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
DE68913774D1 (de) Deodorant sowie deodorierende Lebensmittel, Getränke und Gewürzmittel.
EP1219297A4 (de) Wirkstoffe gegen fettsucht

Legal Events

Date Code Title Description
8364 No opposition during term of opposition